Total Return chart Alkermes plc

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
52.89 ^USD	-0.15%		+0.32%	+89.03%

07-13	Alkermes Announces Interim Results From Long-Term Extension Study Of Alixorexton In Adults With Narcolepsy Type 1 And Type 2	CI
07-13	Alkermes Public's Alixorexton Demonstrates Durable Efficacy in Narcolepsy Patients	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.